
BTSG Stock Forecast & Price Target
BTSG Analyst Ratings
Bulls say
BrightSpring Health is expected to continue their success due to their strong market position, partnerships with drug manufacturers for outcomes-based contracts, and a goal of doubling their business size through acquisitions. However, potential risks include delays in FDA approvals and strained relationships with manufacturers. With a target price of $81, this company is recommended as a Buy due to its strong financial performance and focus on profitable growth.
Bears say
BrightSpring Health is facing challenges in integration and potential regulatory changes, along with competition in the healthcare industry, despite their recent positive financial performance. While they have strategic initiatives in place and partnerships with independent pharmacies, their reliance on the Pharmacy Solutions segment puts them at risk for fluctuations in revenue. Additionally, divesting their community living business may not be enough to improve margins, and the success of their home-based primary care focus remains uncertain.
This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.
BTSG Analyst Forecast & Price Prediction
Start investing in BTSG
Order type
Buy in
Order amount
Est. shares
0 shares